Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3271869rdf:typepubmed:Citationlld:pubmed
pubmed-article:3271869lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0019868lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:3271869lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3271869pubmed:issue1lld:pubmed
pubmed-article:3271869pubmed:dateCreated1990-3-20lld:pubmed
pubmed-article:3271869pubmed:abstractTextThe incubation of isolated rat hepatocytes with extracellular adenosine 5'-triphosphate (ATP) resulted in an inhibition of Ca2+ efflux. The ATP-induced Ca2+ accumulation as determined by the increase in phosphorylase a activity and the Ca2+-sensitive fluorescent indicator (2-[(2-bis-[carboxymethyl]-amino-5-methylphenoxy)-methyl]-6-methoxy-8- bis-[carboxymethyl]aminoquinoline-tetrakis-[acetoxymethyl]ester) (Quin 2-AM) was associated with both the hydrolysis of ATP and the phosphorylation of a 110 kDa protein. No significant alteration in the intracellular ATP level was observed. The appearance of surface blebs and cytotoxicity followed the rise in cytosolic Ca2+, suggesting that the increased free Ca2+ may be responsible for the loss of viability. When a calmodulin inhibitor, 1-[bis(4-chlorophenyl)methyl]-3-[ 2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy] ethyl]-1H- imidazolium chloride (calmidazolium), was included in the medium prior to ATP addition, bleb formation was reduced and the loss of viability was completely prevented, indicating that a Ca2+-calmodulin process may be involved in the initiation of cytotoxicity.lld:pubmed
pubmed-article:3271869pubmed:languageenglld:pubmed
pubmed-article:3271869pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:citationSubsetIMlld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271869pubmed:statusMEDLINElld:pubmed
pubmed-article:3271869pubmed:monthMarlld:pubmed
pubmed-article:3271869pubmed:issn0887-2082lld:pubmed
pubmed-article:3271869pubmed:authorpubmed-author:OrreniusSSlld:pubmed
pubmed-article:3271869pubmed:authorpubmed-author:MooreMMlld:pubmed
pubmed-article:3271869pubmed:authorpubmed-author:BellomoGGlld:pubmed
pubmed-article:3271869pubmed:authorpubmed-author:MirabellaNNlld:pubmed
pubmed-article:3271869pubmed:authorpubmed-author:NicoteraPPlld:pubmed
pubmed-article:3271869pubmed:issnTypePrintlld:pubmed
pubmed-article:3271869pubmed:volume1lld:pubmed
pubmed-article:3271869pubmed:ownerNLMlld:pubmed
pubmed-article:3271869pubmed:authorsCompleteYlld:pubmed
pubmed-article:3271869pubmed:pagination29-39lld:pubmed
pubmed-article:3271869pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:meshHeadingpubmed-meshheading:3271869-...lld:pubmed
pubmed-article:3271869pubmed:year1986lld:pubmed
pubmed-article:3271869pubmed:articleTitleCa2+ homeostasis and cytotoxicity in isolated hepatocytes: studies with extracellular adenosine 5'-triphosphate.lld:pubmed
pubmed-article:3271869pubmed:affiliationDepartment of Toxicology, Karolinska Institutet, Stockholm, Sweden.lld:pubmed
pubmed-article:3271869pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3271869pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3271869lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3271869lld:pubmed